Mineralys Therapeutics, Inc.

MLYS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13D/A Mar 17, 2025
4 Mar 17, 2025
4 Mar 17, 2025
SCHEDULE 13D/A Mar 17, 2025
4 Mar 17, 2025
4 Mar 13, 2025 FORM 4
8-K Mar 12, 2025 8-K
424B5 Mar 12, 2025 424B5
424B5 Mar 10, 2025 424B5
8-K Mar 10, 2025 8-K
4 Feb 24, 2025
4 Feb 24, 2025 FORM 4
4 Feb 24, 2025 FORM 4
4 Feb 24, 2025 FORM 4
4 Feb 24, 2025 FORM 4
4 Feb 24, 2025 FORM 4
4 Feb 24, 2025 FORM 4
4 Feb 24, 2025 FORM 4
4 Feb 24, 2025 FORM 4
4 Feb 24, 2025 FORM 4
SCHEDULE 13G/A Feb 14, 2025
S-8 Feb 14, 2025 S-8
4 Feb 13, 2025 FORM 4
10-K Feb 12, 2025 10-K
8-K Feb 12, 2025 8-K
← Newer Page 9 of 17 · 408 filings Older →